Estimation of pharmacokinetic parameters from non-compartmental variables using Microsoft Excel®

Computers in Biology and Medicine

Volumn 35, Issue 5, 2005, Pages 389-403

  Dansirikul, Chantaratsamon ^a   Choi, Malcolm ^a   Duffull, Stephen B ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Compartment model parameters; Microsoft Excel ; Non compartmental variables; Pharmacokinetic parameters; Solver

Indexed keywords

COMPUTER SIMULATION; COMPUTER SOFTWARE; DATA REDUCTION; MATHEMATICAL MODELS; PARAMETER ESTIMATION; SPREADSHEETS;

BACK ANALYSIS (BA); MICROSOFT EXCEL; RANDOM EFFECT PARAMETERS; VISUAL BASIC FUNCTIONS;

PHARMACOKINETICS;

CYCLOSPORIN A; RAPAMYCIN;

ACCURACY; AREA UNDER THE CURVE; ARTICLE; COMPARTMENT MODEL; COMPUTER PROGRAM; COMPUTER SIMULATION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; MATHEMATICAL COMPUTING; PRIORITY JOURNAL;

COMPUTER SIMULATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MODELS, BIOLOGICAL; PHARMACOKINETICS; SIROLIMUS; SOFTWARE;

EID: 14844342828     PISSN: 00104825     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.compbiomed.2004.02.008     Document Type: Article

References (16)

1. Sheiner L., Wakefield J. Population modelling in drug development. Stat. Methods Med. Res. 8:1999;183-193
2. Holford N.H., Kimko H.C., Monteleone J.P., Peck C.C. Simulation of clinical trials. Annu. Rev. Pharmacol. Toxicol. 40:2000;209-234
3. Burton M.E., Vasko M.R., Brater D.C. Comparison of drug dosing methods. Clin. Pharmacokinet. 10:1985;1-37
4. Gibaldi M. Biopharmaceutics and Clinical Pharmacokinetics. 1991;Lea & Febiger, Philadelphia
5. Gillespie W.R. Noncompartmental versus compartmental modelling in clinical pharmacokinetics. Clin. Pharmacokinet. 20:1991;253-262
6. Bjornsson T.D., Lui N.L., England M.J. Estimation of pharmacokinetic parameters for simulations of time courses of drug concentrations after oral administration. J. Clin. Pharmacol. 34:1994;1046-1052
7. Ferron G.M., Mishina E.V., Zimmerman J.J., Jusko W.J. Population pharmacokinetics of sirolimus in kidney transplant patients. Clin. Pharmacol. Ther. 61:1997;416-428
8. Brattstrom C., Sawe J., Tyden G., Herlenius G., Claesson K., Zimmerman J., Groth C.G. Kinetics and dynamics of single oral doses of sirolimus in sixteen renal transplant recipients. Ther. Drug Monit. 19:1997;397-406
9. Kaplan B., Meier Kriesche H.U., Napoli K.L., Kahan B.D. The effects of relative timing of sirolimus and cyclosporine microemulsion formulation coadministration on the pharmacokinetics of each agent. Clin. Pharmacol. Ther. 63:1998;48-53
10. K. A. Kumi, Approval package for 021083: clinical pharmacology and biopharmaceutics review (s), http://www.fda.gov/cder/foi/nda/99/ 21083A_Rapamune_clinphrmr.pdf, 2001.
11. Zimmerman J.J., Kahan B.D. Pharmacokinetics of sirolimus in stable renal transplant patients after multiple oral dose administration. J. Clin. Pharmacol. 37:1997;405-415
12. Retout S., Duffull S., Mentre F. Development and implementation of the population Fisher information matrix for the evaluation of population pharmacokinetic designs. Comput. Meth. Programs Biomed. 65:2001;141-151
13. Evans W.E., Schentag J.J., Jusko W.J. Applied Pharmacokinetics: Principles of Therapeutic Drug Monitoring, Applied Therapeutics. 1992;Vancouver, WA
14. Chaloner K., Church T., Louis T.A., Matts J.P. Graphical elicitation of a prior distribution for a clinical-trial. Statistician. 42:1993;341-353
15. Tan S.B., Chung Y.F., Tai B.C., Cheung Y.B., Machin D. Elicitation of prior distributions for a phase III randomized controlled trial of adjuvant therapy with surgery for hepatocellular carcinoma. Controlled Clin. Trials. 24:2003;110-121
16. Aarons L. Software for population pharmacokinetics and pharmacodynamics. Clin. Pharmacokinet. 36:1999;255-264